21397058 21235769 12848455 12757356 32985459 10849763 15921919 9856568 35225435 19591933 34526125 32976638 22118736 20854288 22916201 11283202 29511261 9585605 10364509 10624951 15808438 12671660 11895368 15485357 19711252 9605586 14510623 9808447 20 - Search Results

Year	Number of Results
1997	4
1998	7
1999	3
2000	2
2001	1
2002	2
2003	5
2004	1
2005	4
2009	2
2010	3
2011	4
2012	1
2017	1
2018	1
2020	1
2021	2
2022	1

1

Novel deletion encompassing exons 5-12 of the UBE3A gene in a girl with Angelman syndrome.

Beleza-Meireles A, Cerqueira R, Sousa SB, Palmeiro A, Ramos L. Beleza-Meireles A, et al. Eur J Med Genet. 2011 May-Jun;54(3):348-50. doi: 10.1016/j.ejmg.2011.02.010. Epub 2011 Mar 10. Eur J Med Genet. 2011. PMID: 21397058

2

Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome.

Allensworth M, Saha A, Reiter LT, Heck DH. Allensworth M, et al. BMC Genet. 2011 Jan 14;12:7. doi: 10.1186/1471-2156-12-7. BMC Genet. 2011. PMID: 21235769 Free PMC article.

3

Molecular genetic testing for prenatal diagnosis.

Tantravahi U, Wheeler P. Tantravahi U, et al. Clin Lab Med. 2003 Jun;23(2):481-502. doi: 10.1016/s0272-2712(03)00035-0. Clin Lab Med. 2003. PMID: 12848455 Review.

4

Case report: Angelman syndrome in an individual with a small SMC(15) and paternal uniparental disomy: a case report with reference to the assessment of cognitive functioning and autistic symptomatology.

Thompson RJ, Bolton PF. Thompson RJ, et al. J Autism Dev Disord. 2003 Apr;33(2):171-6. doi: 10.1023/a:1022991410822. J Autism Dev Disord. 2003. PMID: 12757356

5

Postnatal therapeutic approaches in genetic neurodevelopmental disorders.

Levy G, Barak B. Levy G, et al. Neural Regen Res. 2021 Mar;16(3):414-422. doi: 10.4103/1673-5374.293133. Neural Regen Res. 2021. PMID: 32985459 Free PMC article. Review.

6

Review: peptidases and peptidase inhibitors in the pathogenesis of diseases. Disturbances in the ubiquitin-mediated proteolytic system. Protease-antiprotease imbalance in inflammatory reactions. Role of cathepsins in tumour progression.

Bank U, Krüger S, Langner J, Roessner A. Bank U, et al. Adv Exp Med Biol. 2000;477:349-78. doi: 10.1007/0-306-46826-3_38. Adv Exp Med Biol. 2000. PMID: 10849763 Review. No abstract available.

7

Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.

Colas D, Wagstaff J, Fort P, Salvert D, Sarda N. Colas D, et al. Neurobiol Dis. 2005 Nov;20(2):471-8. doi: 10.1016/j.nbd.2005.04.003. Neurobiol Dis. 2005. PMID: 15921919

8

Angelman syndrome: are the estimates too low?

Buckley RH, Dinno N, Weber P. Buckley RH, et al. Am J Med Genet. 1998 Dec 4;80(4):385-90. doi: 10.1002/(sici)1096-8628(19981204)80:4<385::aid-ajmg15>3.0.co;2-9. Am J Med Genet. 1998. PMID: 9856568

9

A novel variant in UBE3A in a family with multigenerational intellectual disability and developmental delay.

Zhao X, Zheng Y, Wang L, Wang Y, Mei S, Kong X. Zhao X, et al. Mol Genet Genomic Med. 2022 Apr;10(4):e1883. doi: 10.1002/mgg3.1883. Epub 2022 Feb 28. Mol Genet Genomic Med. 2022. PMID: 35225435 Free PMC article.

10

UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.

Mishra A, Godavarthi SK, Jana NR. Mishra A, et al. Neurobiol Dis. 2009 Oct;36(1):26-34. doi: 10.1016/j.nbd.2009.06.010. Epub 2009 Jul 8. Neurobiol Dis. 2009. PMID: 19591933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results